Olmesartan E Idroclorotiazide Doc (Olmesartan Medoxomil, Hydrochlorothiazide)

Olmesartan medoxil, the active ingredient in Olmesartan E Idroclorotiazide Doc, is an angiotensin II receptor blocker presented as a tablet for oral use. It treats hypertension, often in combination with a diuretic, and is intended for adult patients. GNH USA supplies Olmesartan E Idroclorotiazide Doc as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Olmes tablets as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies through its global network across the world.

Olmesartan medoxil combined with hydrochlorothiazide is used for managing the cardiovascular system pathway of blood pressure regulation:

- Hypertension: Low the overall systolic and diastolic blood pressure. - Heart failure with congestive edema (when approved by regulators in some regions). - Chronic kidney disease related protein ‑ reducing protein uria and protect renal function. -   -  

Olmesartan E